Nuwellis (NUWE) Debt to Equity (2015 - 2016)
Nuwellis (NUWE) reported Debt to Equity of $1.07 for Q2 2016, up 1281.49% on a YoY basis from $0.08 in Q3 2015, and up 110.13% quarter-over-quarter from $0.51 in Q1 2016.
Nuwellis (NUWE) Debt to Equity (2015 - 2016) Analysis & Trends
Nuwellis has reported Debt to Equity for 2 years, with the latest figure at $1.07 in Q2 2016.
- For the quarter ending Q2 2016, Debt to Equity rose 1281.49% year-over-year to $1.07; the trailing twelve-month figure through Jun 2016 stood at $1.07 (up 1281.49% YoY), and the FY2015 full-year result was $0.31, changed N/A from the prior year.
- Debt to Equity for Q2 2016 stood at $1.07, up from $0.51 in the prior quarter.
- The five-year high for Debt to Equity was $1.07 in Q2 2016, with the low at $0.02 in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 0.65 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 0.64 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 0.57 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 0.42 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.06 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.71 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 0.95 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 0.27 |
| 10 | Nuwellis | 279,710.00 | -1.80 Mn | 1.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 1.07 |
| Mar 31, 2016 | 0.51 |
| Dec 31, 2015 | 0.31 |
| Sep 30, 2015 | 0.16 |
| Jun 30, 2015 | 0.08 |
| Mar 31, 2015 | 0.02 |